Stoke Therapeutics Inc buy Chardan Capital
Start price
05.01.26
/
50%
€25.80
Target price
05.01.27
€29.93
Performance (%)
13.10%
Price
07.04.26
€29.18
Summary
This prediction is currently active. The BUY prediction by Chardan_Capital currently has a performance of 13.10%. This prediction currently runs until 05.01.27. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | 4.964% | 4.964% |
| iShares Core DAX® | 2.554% | -0.112% |
| iShares Nasdaq 100 | 2.742% | -0.470% |
| iShares Nikkei 225® | 6.584% | 3.221% |
| iShares S&P 500 | 1.930% | -0.519% |
Comments by Chardan_Capital for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics (NASDAQ:STOK) had its price target raised by analysts at Chardan Capital from $24.00 to $35.00. They now have a "buy" rating on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by Chardan_Capital for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€26.60
18.03.26
18.03.26
€30.34
18.03.27
18.03.27
9.70%
07.04.26
07.04.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€13.80
13.08.25
13.08.25
€20.55
13.08.26
13.08.26
111.45%
07.04.26
07.04.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€8.95
19.02.25
19.02.25
€23.00
19.02.26
19.02.26
221.79%
20.02.26
20.02.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€10.70
20.12.24
20.12.24
€23.06
20.12.25
20.12.25
152.34%
21.12.25
21.12.25